摘要
本文介绍了胃内滞留缓释制剂瑞贝克的研制及临床应用，该制剂在胃内能滞留４～６小时，并缓慢释放药物。药敏试验，对幽门螺旋杆菌高度敏感。对治疗慢性胃炎、消化性溃疡有效率９０．７８％，治疗细菌性肠炎有效率１００％，ＨＰ菌的清除率６９．５１％。本品为新型抗生素缓释制剂。
This paper presents the study and application of SWIBEC stomach-retained and sustained-release tablets, which could retain in stomach for 4～6 hours and release their effective component gradually.The results showed that Helicobacter Phylori (HP)was highly sensitive to SWIBEC. In clinical use, the tablets were effective for 90. 78% of chronic gastritis and peptic ulcer, and 100% of bacterial enteritis with a HP clearance rate of 69.5%. It is a new sustained-relase tablet of antibiotic.
出处
《中国药房》
CAS
CSCD
1995年第1期13-15,共3页
China Pharmacy
